272
Participants
Start Date
March 23, 2018
Primary Completion Date
March 5, 2020
Study Completion Date
March 5, 2020
LY2963016
Administered SC
Lantus®
Administered SC
Insulin Lispro
Administered SC
Peking Union Medical College Hospital, Beijing
Peking University Peoples Hospital, Beijing
Dalian Med. Univ. No 2 Affiliate Hospital, Dalian
No.2 Hospital Affiliated to Jilin University, Changchun
Shanghai Putuo District Center Hospital, Shanghai
Shanghai Tenth People's Hospital, Shanghai
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
Nanjing First Hospital, Nanjing
The First Affiliated Hospital with Nanjing Medical Universit, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
Changzhou No.2 People's Hospital, Changzhou
The Second Xiangya Hospital of Central South University, Changsha
Wu Han Tongji Hospital, Wuhan
The 1st Affiliated Hospital of Henan Science and technology, Luoyang
Guangdong Province People's Hospital, Guangzhou
The First Affiliated Hospital, Sun-Yat Sen University, Guangzhou
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
Shantou University Medical College No.2 Affiliated Hospital, Shantou
West China Hospital of Sichuan University, Chengdu
First People's Hospital of Yunnan Province, Kunming
Eli Lilly and Company
INDUSTRY